Opus Genetics, Inc.
IRD
$0.8998
$0.03484.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -632.74% | -235.34% | -56.52% | -22.71% | -114.13% |
| Total Depreciation and Amortization | 233.33% | -- | -- | -- | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,719.33% | -57.97% | -43.32% | 19.74% | 44.54% |
| Change in Net Operating Assets | -83.70% | 115.53% | -107.36% | -69.92% | 253.76% |
| Cash from Operations | -263.54% | -70.83% | -837.31% | -56.77% | -84.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -91.68% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 73.26% | 2.83% | -- | -- | -1,333.33% |
| Cash from Financing | -102.30% | -93.43% | -- | -- | 30,125.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.43% | -301.31% | -681.60% | 8.39% | -71.68% |